Rosemary Donaldson Cress, M.P.H., Dr.P.H.

Specialties

Cancer

Public Health Sciences-Division of Epidemiology

Title

  • Adjunct Professor

Reviews

Research/Academic Interests

As Principal Investigator of the SEER Cancer Registry of Greater California, Dr. Cress' research interests have been focused on using cancer registry data to identify disparities by race/ethnicity and socioeconomic status in cancer treatment and survival. She has collaborated with UC Davis clinical researchers, particularly those in urologic oncology and gynecologic oncology. She is a member of the UC Davis Comprehensive Cancer Center's Population Sciences and Health Disparities Program, teaches cancer epidemiology, and mentors graduate students.

Division

Epidemiology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center

Education

Dr.P.H., Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans LA 1991

M.P.H., Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans LA 1983

B.S., Education, Miami University, Oxford OH 1971

Select Recent Publications

Klapheke AK, Keegan THM, Ruskin R, Cress RD. Depressive symptoms and health-related quality of life in older women with gynecologic Cancers. J Geriatr Oncol. 2020 Jun;11(5):820-827. doi:10.1016/j.jgo.2019.10.001. Epub 2019 Oct 25. PMID:31668948.

Dall'Era MA, deVere-White R, Rodriguez D, Cress R. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015. Eur Urol Focus. 2019 Nov 1;5(6):p1014-1021. doi:10.1016/j.euf.2018.04.016.

Maguire FB, Morris CR, Parikh-Patel A, Cress RD, Keegan THM, Li CS, Lin PS, Kizer KW. First-Line Systemic Treatments for Stage IV Non-Small Cell Lung Cancer in California: Patterns of Care and Outcomes in a Real-World Setting. JNCI Cancer Spectr. 2019 Sep;3(3):pkz020. doi:10.1093/jncics/pkz020.

Dall'Era MA, Lo MJ, Chen J, Cress R, Hamilton AS. Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer. Cancer. 2018 May 1;124(9):1921-1928. doi:10.1002/cncr.31285. Epub 2018 Mar 2. PMID:29499075.

Chen Y, Cress RD, Stewart SL, Semrad TJ, Harvey D, Tencredi DJ, Beckett L. Mediating Effect of Postsurgical Chemotherapy on Presence of Dementia and Survival among Patients 65 and Older with Stage III Colon Cancer. Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1558-1563. doi:10.1158/1055-9965.EPI-17-0277. PMID:28939585.

Yap SA, Yuh LM, Evans CP, Dall'Era MA, Wagenaar RM, Cress R, Lara PN Jr. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry. World J Urol. 2017 Feb;35(2):277-283. doi:10.1007/s00345-016-1870-y. Epub 2016 Jun 15. PMID:27306686.

Cress RD, Chen YS, Morris CR, Chew H, Kizer KW. Underutilization of gene expression profiling for early-stage breast cancer in California. Cancer Causes Control. 2016 Jun;27(6):721-7. doi:10.1007/s10552-016-0743-4. Epub 2016 Apr 20. PMID:27097910.

David EA, Canter RJ, Chen Y, Cooke DT, Cress RD. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. Ann Thorac Surg. 2016 Oct;102(4):1101-9. doi:10.1016/j.athoracsur.2016.04.058. Epub 2016 Jun 9. PMID:27293147.

Rodriguez DN, Torruellas C, Cress RD. Trends in early-stage hepatocellular carcinoma, California 1988-2010. Cancer Causes Control. 2016;27:325–331. doi:10.1007/s10552-015-0705-2.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Sabatino SA, Wu XC, Wilson JF, Trentham-Dietz A. Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer. Cancer Epidemiol. 2016 Feb;40:7-14. doi:10.1016/j.canep.2015.11.003. Epub 2015 Nov 21. PMID:26605428.